Endocrinology
Glaryl
Glimepiride 1 mg - 30 Tablets
Glimepiride 2 mg - 30 Tablets
Glimepiride 3 mg - 30 Tablets
Glimepiride 4 mg - 30 Tablets
Glimepiride 6 mg - 30 Tablets
Composition:
Glaryl 1 mg Tablet: Each tablet contains 1 mg glimepiride, as active ingredient.
Glaryl 2 mg Tablet: Each tablet contains 2 mg glimepiride, as active ingredient.
Glaryl 3 mg Tablet: Each tablet contains 3 mg glimepiride, as active ingredient.
Glaryl 4 mg Tablet: Each tablet contains 4 mg glimepiride, as active ingredient.
Glaryl 6 mg Tablet: Each tablet contains 6 mg glimepiride, as active ingredient.
Therapeutic Indications:
Glaryl is indicated for the treatment of type 2 diabetes mellitus, when diet, physical exercise and weight
reduction alone are not adequate
Approved by Egyptian Drug Authority: HF0294OA4548/102025 . Invalidation date: 20/10/2026
Kindly report any violated online promotional, educational and awareness material not having this message to The General administration for Regulation of Marketing & Advertising Materials at www.edaegypt.gov.eg”